Forbes: Atropos Health helps doctors, pharma companies and insurers figure out how patients react to treatments in the real-world

Katie Jennings of Forbes sat down with Dr. Brigham Hyde, CEO and co-Founder of Atropos Health to discuss the $33M Series B fundraise.

See the full article here: https://www.forbes.com/sites/katiejennings/2024/05/23/billionaire-jim-breyer-is-backing-this-health-ai-startup-with-a-radical-approach-to-data/

To learn how your organization can generate real-world evidence for healthcare decision-making, contact info@atroposhealth.com.

Previous
Previous

Atropos Health Announces $33M Series B

Next
Next

Becker’s Hospital Review: Weight Loss Drugs and Surgery Complications: New study